Hot Natural Products & Bioactive Compounds
BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.
Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.
Hot Products from BioCrick
Showing 737 - 744 of 9359 hot products
| Catalog No. | Product Name |
|---|---|
| BCC3949 | AY-NH2 |
|
Selective PAR<sub>4</sub> receptor agonist peptide. Stimulates platelet aggregation <em>in vitro</em> (EC<sub>50</sub> = 15 <span class='symbol'>μ</span>M). Exhibits an increase in paw thickness in the paw edema inflammation model <em>in vivo</em>.
|
|
| BCC3950 | Thrombin Receptor Agonist Peptide |
|
Agonist at the thrombin receptor; causes platelet aggregation (EC<sub>50</sub> = 4 <span class='symbol'>μ</span>M) and secretion.
|
|
| BCC3951 | AC 55541 |
|
Potent and selective protease-activated receptor 2 (PAR<sub>2</sub>) agonist (pEC<sub>50</sub> = 6.7) that displays no activity at other PAR subtypes or at over 30 other receptors involved in nociception and inflammation. Stimulates cell proliferation, PI hydrolysis and Ca<sup>2+</sup> mobilization <em>in vitro</em> (pEC<sub>50</sub> values are 6.7, 5.9 and 6.6 respectively) and exhibits pronociceptive activity <em>in vivo</em>.
|
|
| BCC3952 | AC 264613 |
|
Potent and selective protease-activated receptor 2 (PAR<sub>2</sub>) agonist (pEC<sub>50</sub> = 7.5). Displays no activity at other PAR subtypes and exhibits no significant activity at over 30 other receptors implicated in nociception and inflammation. Stimulates PI hydrolysis, Ca<sup>2+</sup> mobilization and cellular proliferation <em>in vitro</em> (pEC<sub>50</sub> values are 6.9, 7.0 and 7.5 respectively).
|
|
| BCC3953 | VKGILS-NH2 |
|
Reversed amino acid sequence control peptide for SLIGKV-NH<sub>2</sub>, a protease-activated receptor 2 (PAR<sub>2</sub>) agonist.
|
|
| BCC3954 | RLLFT-NH2 |
|
Reversed amino acid sequence control peptide for TFLLR-NH<sub>2</sub>, a PAR<sub>1</sub> selective agonist that significantly increases nociceptive threshold.
|
|
| BCC3955 | LRGILS-NH2 |
|
Reversed amino acid sequence control peptide for SLIGRL-NH<sub>2</sub>, a protease-activated receptor-2 (PAR<sub>2</sub>) agonist that facilitates gastrointestinal transit <em>in vivo</em>.
|
|
| BCC3956 | PAR 4 (1-6) |
|
N-terminal fragment of protease-activated receptor 4 (PAR4) that acts as a PAR4 agonist. Induces aggregation of human platelets.
|
|